| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 31.113 | 31.908 | 29.350 | 39.317 | 38.317 | 42.096 | 23.827 | 9.764 | 15.405 | 13.184 |
| Total Income - EUR | 32.032 | 32.407 | 30.665 | 40.008 | 40.263 | 44.264 | 26.043 | 9.764 | 15.405 | 13.184 |
| Total Expenses - EUR | 21.396 | 21.235 | 23.808 | 25.525 | 26.278 | 29.018 | 18.432 | 7.675 | 12.432 | 12.367 |
| Gross Profit/Loss - EUR | 10.636 | 11.172 | 6.857 | 14.483 | 13.985 | 15.246 | 7.611 | 2.089 | 2.973 | 817 |
| Net Profit/Loss - EUR | 9.676 | 10.848 | 6.550 | 14.086 | 13.580 | 14.822 | 7.205 | 1.840 | 2.819 | 395 |
| Employees | 3 | 3 | 3 | 3 | 2 | 2 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Dorimed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 842 | 13.116 | 9.482 | 7.015 | 4.196 | 782 | 188 | 0 | 0 | 0 |
| Current Assets | 43.000 | 27.794 | 27.731 | 42.104 | 38.336 | 55.874 | 15.986 | 3.532 | 9.759 | 3.393 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 320 | 0 |
| Receivables | 18.489 | 7.947 | 816 | 3.499 | 2.877 | 3.034 | 0 | 730 | 1.747 | 0 |
| Cash | 24.511 | 19.847 | 26.915 | 38.605 | 35.459 | 52.841 | 15.986 | 2.802 | 7.692 | 3.393 |
| Shareholders Funds | 39.557 | 36.946 | 32.206 | 45.701 | 38.278 | 52.374 | 15.860 | 3.331 | 3.296 | 3.672 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 4.285 | 3.964 | 5.006 | 3.418 | 4.254 | 4.282 | 314 | 201 | 6.463 | 609 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Dorimed Srl